These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 11268266

  • 21. Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Asztalos BF, Collins D, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ.
    Metabolism; 2008 Jan; 57(1):77-83. PubMed ID: 18078862
    [Abstract] [Full Text] [Related]

  • 22. Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).
    Robins SJ, Collins D, McNamara JR, Bloomfield HE.
    Atherosclerosis; 2008 Feb; 196(2):849-55. PubMed ID: 17335828
    [Abstract] [Full Text] [Related]

  • 23. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 24. A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.
    Syvänne M, Taskinen MR, Nieminen, Manninen V, Kesäniemi YA, Pasternack A, Nawrocki JW, Haber H, Frick MH.
    Control Clin Trials; 1997 Feb 15; 18(1):93-119. PubMed ID: 9055055
    [Abstract] [Full Text] [Related]

  • 25. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH.
    Circulation; 1992 Jan 15; 85(1):37-45. PubMed ID: 1728471
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Gemfibrozil prevents major coronary events by increasing HDL-cholesterol and more.
    Doggrell SA.
    Expert Opin Pharmacother; 2001 Jul 15; 2(7):1187-9. PubMed ID: 11583069
    [Abstract] [Full Text] [Related]

  • 30. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC, Nurmohamed MT, Van den Ende A, Plaat B, Pruijs HJ, Mulder WJ, Kastelein JJ.
    J Intern Med; 1994 Oct 15; 236(4):377-84. PubMed ID: 7931040
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HDL and triglyceride as therapeutic targets.
    Fruchart JC, Duriez P.
    Curr Opin Lipidol; 2002 Dec 15; 13(6):605-16. PubMed ID: 12441884
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M, Nieminen MS, Frick MH, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Ehnholm C, Taskinen MR.
    Circulation; 1998 Nov 10; 98(19):1993-9. PubMed ID: 9808595
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW.
    Am J Cardiovasc Drugs; 2005 Nov 10; 5(6):379-87. PubMed ID: 16259526
    [Abstract] [Full Text] [Related]

  • 37. Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations.
    Rubins HB, Robins SJ.
    J Intern Med; 1992 Apr 10; 231(4):421-6. PubMed ID: 1588269
    [Abstract] [Full Text] [Related]

  • 38. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M, Roberts A, Davies S, Rees A.
    Drugs; 2004 Apr 10; 64(11):1181-96. PubMed ID: 15161326
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.